<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08904121810130</udiDi>
    <basicUdiDi>B-08904121810130</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0013</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:22.524Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810123</udiDi>
    <basicUdiDi>B-08904121810123</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7513</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:20.117Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810116</udiDi>
    <basicUdiDi>B-08904121810116</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5013</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:16.512Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810109</udiDi>
    <basicUdiDi>B-08904121810109</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2513</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:14.094Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810093</udiDi>
    <basicUdiDi>B-08904121810093</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0013</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:12.896Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810086</udiDi>
    <basicUdiDi>B-08904121810086</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5008</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:09.306Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810079</udiDi>
    <basicUdiDi>B-08904121810079</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0008</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:05.693Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810062</udiDi>
    <basicUdiDi>B-08904121810062</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5008</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:03.306Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810055</udiDi>
    <basicUdiDi>B-08904121810055</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0008</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:02.094Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810048</udiDi>
    <basicUdiDi>B-08904121810048</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7508</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:59.688Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810031</udiDi>
    <basicUdiDi>B-08904121810031</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5008</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:56.115Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810024</udiDi>
    <basicUdiDi>B-08904121810024</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2508</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:53.802Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810017</udiDi>
    <basicUdiDi>B-08904121810017</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0008</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:51.290Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121808724</udiDi>
    <basicUdiDi>B-08904121808724</basicUdiDi>
    <tradeName>genXSync Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>genXSync Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC2.1 4.5040</reference>
    <placedOnMarketCountry>Luxembourg</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:48.896Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121808717</udiDi>
    <basicUdiDi>B-08904121808717</basicUdiDi>
    <tradeName>genXSync Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>genXSync Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC2.1 4.0040</reference>
    <placedOnMarketCountry>Luxembourg</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:45.288Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121808700</udiDi>
    <basicUdiDi>B-08904121808700</basicUdiDi>
    <tradeName>genXSync Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>genXSync Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC2.1 3.5040</reference>
    <placedOnMarketCountry>Luxembourg</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:42.875Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121808694</udiDi>
    <basicUdiDi>B-08904121808694</basicUdiDi>
    <tradeName>genXSync Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>genXSync Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC2.1 3.0040</reference>
    <placedOnMarketCountry>Luxembourg</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:41.681Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121808687</udiDi>
    <basicUdiDi>B-08904121808687</basicUdiDi>
    <tradeName>genXSync Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>genXSync Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC2.1 2.7540</reference>
    <placedOnMarketCountry>Luxembourg</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:39.278Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121808670</udiDi>
    <basicUdiDi>B-08904121808670</basicUdiDi>
    <tradeName>genXSync Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>genXSync Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC2.1 2.5040</reference>
    <placedOnMarketCountry>Luxembourg</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:34.482Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121808663</udiDi>
    <basicUdiDi>B-08904121808663</basicUdiDi>
    <tradeName>genXSync Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>genXSync Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC2.1 2.2540</reference>
    <placedOnMarketCountry>Luxembourg</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:14:32.079Z</lastUpdated>
  </row>
</eudamedExport>